Series 87 FAQ — Common Questions About Eligibility, Scope, and Study Strategy

Common questions about the FINRA Series 87 exam, including sponsorship, the SIE and Series 86 relationship, exam scope, and practical study strategy.

On this page

Policies can change—confirm critical details with FINRA before scheduling.

Quick links:

Quick facts

  • Reference question count: 50
  • Reference time: 105 minutes
  • Passing score: 74
  • Cost: $195
  • Top weighted topic: Function 4 — Preparation of Research Reports (36 of 50 scored items)

Frequently asked questions

Do I need firm sponsorship for Series 87?

Yes. FINRA states candidates must be associated with and sponsored by a FINRA member firm or other applicable self-regulatory organization member firm to be eligible for representative-level qualification exams.

Does Series 87 have a co-requisite?

Yes. The SIE is part of the Research Analyst qualification path. FINRA states candidates normally need the SIE plus Series 86 and Series 87 to obtain the Research Analyst registration.

Does Series 87 stand alone as a research compliance exam?

No. Series 87 is the regulatory half of the Research Analyst qualification path, not a stand-alone compliance registration. It only makes sense when read together with the broader research-analyst route.

How is Series 87 different from Series 86?

Series 86 is the analytical half of the Research Analyst path. Series 87 is the regulatory half. Series 86 tests modeling, valuation, forecasting, and recommendation logic. Series 87 tests the rules governing research reports, disclosures, conflicts, dissemination, supervision, and what can or cannot be done around the research-publication process.

Do I need Series 86 as well for Series 87?

Usually, yes. Series 87 is only Part II of the Research Analyst path. Unless a valid Series 86 exemption applies, the registration normally requires Series 86, Series 87, and the SIE together.

Is there an exemption from Series 87?

No standard exemption is described for Series 87 in the way FINRA describes exemptions for Series 86. The usual exemption discussion applies to Series 86 only, so Series 87 remains the regulatory half of the path.

What does Series 87 cover?

Series 87 is the regulatory half of the Research Analyst qualification path. FINRA organizes it around preparation of research reports and dissemination of information. In practice, that means disclosures, conflicts, content standards, approvals, restricted activities, and the rules that govern how research is distributed or used.

What is Series 87 really testing beyond disclosure lists?

It is testing whether you understand the governance of research production and dissemination. The stronger answer usually depends on who can do what, what conflicts exist, what must be disclosed, what approvals or restrictions apply, and what the rules allow at each stage of the report lifecycle.

What kind of role usually needs Series 87?

Series 87 usually fits professionals who prepare or contribute to published research under the Research Analyst registration path rather than general sales or trading roles. The exam matters when the role involves regulated research-report preparation, public dissemination, and the associated disclosure and conflict-control framework.

Who supervises registered research analysts on the Series 87 path?

Series 87 does not itself create supervisory authority. FINRA treats research supervision separately from the analyst qualification path. That is why candidates should not assume that passing the regulatory half of the Research Analyst exam makes them the supervising principal for research functions.

How should I allocate study time for Series 87?

Start with Function 4 because it carries most of the exam and covers the core disclosure and report-preparation framework. Then move into Function 5 to lock in the dissemination, communication, and conduct restrictions that apply after the report is prepared.

Which Series 87 section deserves the most study time?

Preparation of research reports deserves the most time because it carries most of the exam and contains the core conflict, disclosure, and content-control framework. Dissemination and marketing still matter, but they make more sense once the preparation rules are already stable.

What is the biggest Series 87 trap?

The common mistake is treating Series 87 like a simple disclosure checklist. The stronger answers usually turn on role boundaries, conflicts, approval and supervision logic, and what can or cannot happen around report preparation and dissemination.

Should I study Series 87 like a report-writing exam or a conduct exam?

Treat it as a research-governance exam. It touches report content, but it is really testing the rules, controls, conflicts, approvals, and dissemination boundaries around research production.

How should I use practice questions for Series 87?

Use a drill-first approach by function, then switch to timed mixed sets. Series 87 improves once you can connect disclosure rules, research-report structure, and dissemination restrictions instead of memorizing them as separate lists.

When should I switch from chapter drills to mixed Series 87 sets?

Switch once you can reliably tell whether a question is really about preparation, dissemination, conflicts, or supervision. Mixed sets matter because the exam becomes harder when those themes are blended and the correct answer depends on where in the report lifecycle the issue arises.

How do I review Series 87 misses effectively?

Write a one-line reason for each miss and classify it as one of these:

  • report-preparation or disclosure problem
  • conflict-of-interest problem
  • dissemination or communications problem
  • supervision or approval problem

That makes retesting more useful than broad rereading.

What is the retake policy for Series 87?

FINRA retake waiting periods can depend on attempt count and exam type. Confirm the current rule before rescheduling.

Revised on Thursday, April 23, 2026